The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Twenty Questions, Part 1

Twenty Questions, Part 1

February 1, 2007 • By David S. Pisetsky, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Every time I see a patient in the clinic, I do a formal count of tender and swollen joints (hands but no feet), get a sed rate, and ask the patient for a global assessment score. Initially, I used a Web site to calculate the DAS, having to Google it every time. Eventually, one of the drug reps gave me a nice little computer for the DAS. I call it my DASometer, and I carry in the pocket of my long white coat every time I go to clinic.

You Might Also Like
  • Readers Answer ‘Twenty Questions’
  • Twenty Questions, Part 2
  • Letters to the Editor
Explore This Issue
February 2007
Also By This Author
  • Medical Renaissance

The intricacies and vagaries of the DAS fascinate me. When I have a moment free in clinic, I conjure all kinds of combinations to put the DAS through its paces. I punch in numbers to obtain values that come from a formula worthy of nuclear physics in its square roots and logarithms. I also play games and try to figure out which patient has a higher DAS: someone with five swollen joints and a sed rate of 20 or someone with one tender joint and a sed rate of 10. My fellows think I am crazy to pursue these entertainments but there is method to my madness.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

My third reason for using the DAS is practical. The DAS helps guide the use of biologics in my clinic where I must approve every prescription for these expensive agents. When one of the fellows asks me for a biologic for a patient, my first question is, “What is the patient’s DAS?” I then examine the patient myself to confirm the number. This endeavor has made the fellows as well as me much more assiduous in our physical exam and has led to discussions of almost a metaphysical import. “What is swelling?” “What is tenderness?” “Can swelling ever go away?”

Surprises and Lessons

In the process of using the DAS, I have discovered that I really don’t understand RA and the meaning of active disease. For example, I saw a patient recently who was a bricklayer working full-time. He was on only methotrexate and, because he was so functional, I thought that the treatment was adequate. A detailed exam showed a slew of tender joints and a bona fide DAS28 of 4.5. I feared that trouble loomed ahead for this man and we began a TNF blocker.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

My enthusiasm for the DAS has grown the more I use it,and I asked the drug rep who gave me my DASometer to get one for each of our fellows. Now the fellows are following patients with this measure. I beam as they come to me and say, “I have a patient with RA who has a DAS of 3.9. What do you think we should do?” Like specialists who use cholesterol values as milestones or juggle drugs to keep the blood pressure down, I feel solidly in the mainstream of medicine.

Next Step: The HAQ

I am now pretty good at the DAS and don’t really need the calculator to tell me where I am on the color-coded scale, where green is good and red is bad.

Pages: 1 2 3 | Single Page

Filed Under: Opinion, Practice Management, Quality Assurance/Improvement, Rheuminations Tagged With: DAS, disease activity score, HAQ, Health Assessment Questionnaire, rheumatologistIssue: February 2007

You Might Also Like:
  • Readers Answer ‘Twenty Questions’
  • Twenty Questions, Part 2
  • Letters to the Editor
  • Remission Definitions in RA: Common Questions & Implications for Clinical Practice

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)